Literature DB >> 28218005

Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging.

Pustika Amalia Wahidiyat1, Felix Liauw2, Damayanti Sekarsari3, Siti Ayu Putriasih2, Vasili Berdoukas4, Dudley J Pennell5.   

Abstract

OBJECTIVES: Recent advancements have promoted the use of T2* magnetic resonance imaging (MRI) in the non-invasive detection of iron overload in various organs for thalassemia major patients. This study aims to determine the iron load in the heart and liver of patients with thalassemia major using T2* MRI and to evaluate its correlation with serum ferritin level and iron chelation therapy.
METHODS: This cross-sectional study included 162 subjects diagnosed with thalassemia major, who were classified into acceptable, mild, moderate, or severe cardiac and hepatic iron overload following their T2* MRI results, respectively, and these were correlated to their serum ferritin levels and iron chelation therapy.
RESULTS: The study found that 85.2% of the subjects had normal cardiac iron stores. In contrast, 70.4% of the subjects had severe liver iron overload. A significant but weak correlation (r = -0.28) was found between cardiac T2* MRI and serum ferritin, and a slightly more significant correlation (r = 0.37) was found between liver iron concentration (LIC) and serum ferritin. DISCUSSION: The findings of this study are consistent with several other studies, which show that patients generally manifest with liver iron overload prior to cardiac iron overload. Moreover, iron accumulation demonstrated by T2* MRI results also show a significant correlation to serum ferritin levels.
CONCLUSION: This is the first study of its kind conducted in Indonesia, which supports the fact that T2* MRI is undoubtedly valuable in the early detection of cardiac and hepatic iron overload in thalassemia major patients.

Entities:  

Keywords:  T2* MRI; cardiac iron; hepatic iron; thalassemia major

Mesh:

Substances:

Year:  2017        PMID: 28218005     DOI: 10.1080/10245332.2017.1292614

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  11 in total

1.  Magnetic resonance imaging during management of patients with transfusion-dependent thalassemia: a single-center experience.

Authors:  Zeynep Karakas; Yasin Yilmaz; Zuhal Bayramoglu; Serap Karaman; Selime Aydogdu; Ayse Ozkan Karagenc; Deniz Tugcu; Memduh Dursun
Journal:  Radiol Med       Date:  2018-04-16       Impact factor: 3.469

2.  Increased myocardial extracellular volume is associated with myocardial iron overload and heart failure in thalassemia major.

Authors:  Antonella Meloni; Laura Pistoia; Vincenzo Positano; Antonio De Luca; Nicola Martini; Anna Spasiano; Ilaria Fotzi; Pier Paolo Bitti; Domenico Visceglie; Gianna Alberini; Gianfranco Sinagra; Alessia Pepe; Filippo Cademartiri
Journal:  Eur Radiol       Date:  2022-09-06       Impact factor: 7.034

3.  N-terminal-pro-b-type natriuretic peptide levels and cardiac hemosiderosis in adolescent β-thalassemia major patients.

Authors:  Ahmad Kautsar; Najib Advani; Murti Andriastuti
Journal:  Ann Pediatr Cardiol       Date:  2019 Jan-Apr

4.  The application value of ultra-short echo time MRI in the quantification of liver iron overload in a rat model.

Authors:  Qiaoling Wu; Xiuwei Fu; Zhizheng Zhuo; Mingfeng Zhao; Hongyan Ni
Journal:  Quant Imaging Med Surg       Date:  2019-02

5.  Iron overload assessment in β Thalassemia Major - is T2* Magnetic Resonance Imaging the answer?

Authors:  Natasha Ali
Journal:  Electron Physician       Date:  2017-10-25

6.  Myocardial Effective Transverse Relaxation Time T 2* is Elevated in Hypertrophic Cardiomyopathy: A 7.0 T Magnetic Resonance Imaging Study.

Authors:  Till Huelnhagen; Min-Chi Ku; Henning Matthias Reimann; Teresa Serradas Duarte; Andreas Pohlmann; Bert Flemming; Erdmann Seeliger; Christina Eichhorn; Victor A Ferrari; Marcel Prothmann; Jeanette Schulz-Menger; Thoralf Niendorf
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

7.  Iron Overload in Transfusion-Dependent Indonesian Thalassemic Patients.

Authors:  Pandji Irani Fianza; Anita Rahmawati; Sri Hudaya Widihastha; Shofura Afifah; Mohammad Ghozali; Andre Indrajaya; Dilli Marayuzan Akbar Pratama; Dimmy Prasetya; Teddy Arnold Sihite; Mas Rizky A A Syamsunarno; Djatnika Setiabudi; Suthat Fucharoen; Ramdan Panigoro
Journal:  Anemia       Date:  2021-04-15

8.  T2-weighted cardiovascular magnetic resonance and echocardiographic arterial elasticity criteria for monitoring cardiac siderosis in patients with beta-thalassemia major.

Authors:  Reihaneh Zavar; Moien Hendimarjan; Mohaddeseh Behjati; Dalir Yazdani
Journal:  J Res Med Sci       Date:  2022-06-30       Impact factor: 1.985

9.  Effective method of evaluating myocardial iron concentration in pediatric patients with thalassemia major.

Authors:  Arwa Khaled; Dina A Ezzat; Hoda A Salem; Hadeel M Seif; Hoda Rabee
Journal:  J Blood Med       Date:  2019-07-12

10.  Comparison of liver MRI R2(FerriScan®) VS liver MRI T2* as a measure of body iron load in a cohort of beta thalassaemia major patients.

Authors:  Padmapani Padeniya; Shirom Siriwardana; Dileepa Ediriweera; Nayana Samarasinghe; Sasanka Silva; Ishari Silva; Nizri Ahamed; Madunil Niriella; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2020-01-22       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.